Alternative Investments - Gold, Commodities, Bitcoin, etc.

Tag: stock analysis

Illustration of a coal mine with a confident investor studying charts while bullish insider buying collides with bearish market forces, highlighting Alpha Metallurgical Resources (AMR) stock analysis and commodity investing risk.

Alpha Metallurgical Resources (AMR) Stock Analysis: Should You Follow a $26 Million Insider Buying Spree?

Alpha Metallurgical Resources (NYSE: AMR) looks compelling on paper: legendary insider buying, aggressive buybacks and a pristine balance sheet. But commodity cycles, recent losses and long-term industry headwinds suggest caution may still be the wiser investment.

Read entire article

Tags: Alpha Metallurgical Resources, AlphaMetallurgical, AMR, AMR stock, BlackRock, buy or sell AMR, coal stocks, CoalStocks, Commodities, commodity investing, CyclicalIndustry, FUNanc1al, insider buying, InsiderBuying, Kenneth Courtis, KennethCourtis, metallurgical coal, mining stocks, Renaissance Technologies, risks buying AMR, short squeeze, ShortSqueeze, steel industry, stock analysis, value investing, ValueInvesting, Wall Street, why buy AMR
Futuristic titanium production facility with robotic arms and molten metal representing IperionX’s 24/7 manufacturing and U.S. supply chain innovation

🦾 IperionX (IPX): The Titanium Disruptor Powering America’s Supply Chain Revolution

IperionX (IPX) is turning from a science experiment into a 24/7 titanium production story—with insiders buying, institutions circling, and the U.S. government backing the mission. The upside looks massive. So do the risks.

Read entire article

Tags: buy or sell IPX, CEO Anastasios Arima, CEO buying IPX, CEO buys IPX, Chairman buys IPX, Chairman Todd Hannigan, critical minerals, CriticalMinerals, defense stocks, DefenseStocks, ESG investing, featured-diversify, featured-insiders, FUNanc1al, growth investing, GrowthInvesting, high growth stocks, hub-diversify, hub-insiders, hub-ipos, insider buying, InsiderBuying, IperionX, IPX, IPX stock, rare earth metals, risks buying IPX, small cap stocks, speculative stocks, stock analysis, supply chain reshoring, titanium stocks, TitaniumStock, US manufacturing, why buy IPX
Illustration of a futuristic life science research campus under reconstruction, with cranes and glowing laboratory buildings, symbolizing Alexandria Real Estate’s turnaround in biotech real estate.

Alexandria Real Estate (ARE): The Life Science “Dr. Frankenstein” Pivot — Rebuilding the Lab from the Floor Up

Alexandria Real Estate (ARE) is the king of life science labs—and one of the most punished REITs of the last five years. After a brutal dividend cut, asset write-downs, and a 75% drawdown, the founder just bought $1.3M of stock and the company is buying back shares. Is this a broken experiment—or a classic cycle-bottom setup?

 

Read entire article

Tags: Alexandria Real Estate, ARE, Biotech, Biotech Real Estate, BiotechInvesting, BiotechTurnarounds, buy or sell ARE, Dividend Stocks, featured-diversify, featured-insiders, FUNanc1al, FUNanc1al Edge, Healthcare Real Estate, hub-diversify, hub-insiders, Income Investing, Insider Buying, Lab Space, Life Science REIT, Real Estate Investing, REIT, risks buying ARE, Stock Analysis, Turnaround Stocks, Value Investing, why buy ARE